leadf
logo-loader
viewCallitas Health Inc

Callitas Therapeutics signs LOI with Simply Wholeistic, updates on THC & CBD candy patent

Callitas Therapeutics (CSE:LILY) (OTCQB:MPHMF) Vice President of Sales & Business Development Joshua Maurice tells Proactive Investors the pharma company has signed a letter of intent with Simply Wholeistic to manufacture  its CannaStrip products in the U.S.

Maurice added that as of today the Ohio-based company also received preliminary approval for a patent on a hard shell candy that delivers THC and CBD through oral absorption.

Quick facts: Callitas Health Inc

Price: - CAD

CSE:LILY
Market: CSE
Market Cap: -
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

NexTech AR Solutions booked 900,000 dollars in InfernoAR business in the...

  NexTech AR Solutions (OTCQB: NEXCF-CSE: NTAR) CEO Evan Gappelberg joined Steve Darling from Proactive to share the news that from September 1st to September 22nd the company has booked $900,000 dollars for their InfernoAR platform. Gappelberg discusses all the business they are...

5 minutes ago

2 min read